Article
Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.
Pharmacogenomics - 1 Oct 2017
Scott Stuart A, Owusu Obeng Aniwaa, Botton Mariana R, Yang Yao, Scott Erick R, Ellis Stephen B, Wallsten Richard, Kaszemacher Tom, Zhou Xiang, Chen Rong, Nicoletti Paola, Naik Hetanshi, Kenny Eimear E, Vega Aida, Waite Eva, Diaz George A, Dudley Joel, Halperin Jonathan L, Edelmann Lisa, Kasarskis Andrew, Hulot Jean-Sébastien, Peter Inga, Bottinger Erwin P, Hirschhorn Kurt, Sklar Pamela, Cho Judy H, Desnick Robert J, Schadt Eric E
Abstract excerpt
For almost 50 years, the Icahn School of Medicine at Mount Sinai has continually invested in genetics and genomics, facilitating a healthy ecosystem that provides widespread support for the ongoing programs in translational pharmacogenomics. These programs can be broadly cataloged into discovery, education, clinical implementation and testing, which are collaboratively accomplished by multiple departments,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.